# Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery

> **NCT06210165** · NA · UNKNOWN · sponsor: **Rhendra Hardy Mohamad Zaini** · enrollment: 80 (estimated)

## Conditions studied

- Atelectasis, Postoperative
- Pulmonary Function; Newborn, Abnormal

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine and atropine

## Key facts

- **NCT ID:** NCT06210165
- **Lead sponsor:** Rhendra Hardy Mohamad Zaini
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-07
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210165, "Effects of Sugammadex and Conventional Reversal on Lung Function in Laparoscopic Abdominal Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06210165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*